• 1
    Yewdell, J. W. and Bennink, J. R., Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 1999. 17: 5188.
  • 2
    Price, D. A., West, S. M., Betts, M. R., Ruff, L. E., Brenchley, J. M., Ambrozak, D. R., Edghill-Smith, Y. et al., T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 2004. 21: 793803.
  • 3
    Sacre, K., Carcelain, G., Cassoux, N., Fillet, A. M., Costagliola, D., Vittecoq, D., Salmon, D. et al., Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J. Exp. Med. 2005. 201: 19992010.
  • 4
    Frahm, N., Kiepiela, P., Adams, S., Linde, C. H., Hewitt, H. S., Sango, K., Feeney, M. E. et al., Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat. Immunol. 2006. 7: 173178.
  • 5
    Smith, C. L., Mirza, F., Pasquetto, V., Tscharke, D. C., Palmowski, M. J., Dunbar, P. R., Sette, A. et al., Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara. J. Immunol. 2005. 175: 84318437.
  • 6
    Chen, W., Anton, L. C., Bennink, J. R. and Yewdell, J. W., Dissecting the multifactorial causes of immunodominance. Immunity 2000. 12: 8393.
  • 7
    Kedl, R. M., Kappler, J. W. and Marrack, P., Epitope dominance, competition and T cell affinity maturation. Curr. Opin. Immunol. 2003. 15: 120127.
  • 8
    Kedl, R. M., Rees, W. A., Hildeman, D. A., Schaefer, B., Mitchell, T., Kappler, J. W. and Marrack, P., T cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 2000. 192: 11051114.
  • 9
    Kedl, R. M., Schaefer, B. C., Kappler, J. W. and Marrack, P., T cells down-modulate peptide-MHC complexes on APCs in vivo. Nat. Immunol. 2002. 3: 2732.
  • 10
    Butz, E. A. and Bevan, M. J., Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 1998. 8: 167175.
  • 11
    Probst, H. C., Dumrese, T. and van den Broek, M. F., Cutting edge: competition for APC by CTLs of different specificities is not functionally important during induction of antiviral responses. J. Immunol. 2002. 168: 53875391.
  • 12
    Scherer, A., Salathe, M. and Bonhoeffer, S., High epitope expression levels increase competition between T cells. PLoS Comput. Biol. 2006. 2: e109.
  • 13
    Busch, D. H. and Pamer, E. G., MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL. J. Immunol. 1998. 160: 44414448.
  • 14
    Van Der Burg, S. H., Visseren, M. J., Brandt, R. M., Kast, W. M. and Melief, C. J., Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 1996. 156: 33083314.
  • 15
    Howarth, M., Williams, A., Tolstrup, A. B. and Elliott, T., Tapasin enhances MHC class I peptide presentation according to peptide half-life. Proc. Natl. Acad. Sci. USA 2004. 101: 1173711742.
  • 16
    Thirdborough, S. M., Roddick, J. S., Radcliffe, J. N., Howarth, M., Stevenson, F. K. and Elliott, T., Tapasin shapes immunodominance hierarchies according to the kinetic stability of peptide-MHC class I complexes. Eur. J. Immunol. 2008. 38: 364369.
  • 17
    Henrickson, S. E., Mempel, T. R., Mazo, I. B., Liu, B., Artyomov, M. N., Zheng, H., Peixoto, A. et al., T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nat. Immunol. 2008. 9: 282291.
  • 18
    Zheng, H., Jin, B., Henrickson, S. E., Perelson, A. S., von Andrian, U. H. and Chakraborty, A. K., How antigen quantity and quality determine T-cell decisions in lymphoid tissue. Mol. Cell. Biol. 2008. 28: 40404051.
  • 19
    Weaver, J. M., Chaves, F. A. and Sant, A. J., Abortive activation of CD4 T cell responses during competitive priming in vivo. Proc. Natl. Acad. Sci. USA 2009. 106: 86478652.
  • 20
    Mylin, L. M., Bonneau, R. H., Lippolis, J. D. and Tevethia, S. S., Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J. Virol. 1995. 69: 66656677.
  • 21
    Kastenmuller, W., Gasteiger, G., Gronau, J. H., Baier, R., Ljapoci, R., Busch, D. H. and Drexler, I., Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination. J. Exp. Med. 2007. 204: 21872198.
  • 22
    Xie, Y. C., Hwang, C., Overwijk, W., Zeng, Z., Eng, M. H., Mule, J. J., Imperiale, M. J. et al., Induction of tumour antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen. J. Natl. Cancer Inst. 1999. 91: 169175.
  • 23
    Rice, J., Elliott, T., Buchan, S. L. and Stevenson, F. K., DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines. J. Immunol. 2001. 167: 15581565.
  • 24
    Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R. et al., Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 1995. 92: 34393443.
  • 25
    Grossmann, M. E., Davila, E. and Celis, E., Avoiding tolerance against prostatic antigens with subdominant peptide epitopes. J. Immunother. 2001. 24: 237241.
  • 26
    Schell, T. D., Knowles, B. B. and Tevethia, S. S., Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas. Cancer Res. 2000. 60: 30023012.
  • 27
    Schell, T. D., In vivo expansion of the residual tumor antigen-specific CD8+T lymphocytes that survive negative selection in Simian virus 40 T-antigen-transgenic mice. J. Virol. 2004. 78: 17511762.
  • 28
    Ryan, C. M. and Schell, T. D., Accumulation of CD8+ T cells in advanced-stage tumors and delay of disease progression following secondary immunization against an immunorecessive epitope. J. Immunol. 2006. 177: 255267.
  • 29
    Rice, J., Ottensmeier, C. H. and Stevenson, F. K., DNA vaccines: precision tools for activating effective immunity against cancer. Nat. Rev. Cancer 2008. 8: 108120.
  • 30
    Fu, T-M., Mylin, L. M., Schell, T. D., Bacik, I., Russ, G., Yewdell, J. W., Bennink, J. R. and Tevethia, S. S., An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope. J. Virol. 1998. 72: 14691481.
  • 31
    Wang, Y., O'Malley, B. W., Jr., Tsai, S. Y. and O'Malley, B. W., A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 1994. 91: 81808184.
  • 32
    Radcliffe, J. N., Roddick, J. S., Stevenson, F. K. and Thirdborough, S. M., Prolonged antigen expression following DNA vaccination impairs effector CD8+ T-cell function and memory development. J. Immunol. 2007. 179: 83138321.
  • 33
    Sandberg, J. K., Grufman, P., Wolpert, E. Z., Franksson, L., Chambers, B. J. and Karre, K., Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. J. Immunol. 1998. 160: 31633169.
  • 34
    Wolpert, E. Z., Grufman, P., Sandberg, J. K., Tegnesjo, A. and Karre, K., Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes. J. Immunol. 1998. 161: 44994505.
  • 35
    Grufman, P., Sandberg, J. K., Wolpert, E. Z. and Karre, K., Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens. J. Leukoc. Biol. 1999. 66: 268271.
  • 36
    Grufman, P., Wolpert, E. Z., Sandberg, J. K. and Karre, K., T cell competition for the antigen-presenting cell as a model for immunodominance in the cytotoxic T lymphocyte response against minor histocompatibility antigens. Eur. J. Immunol. 1999. 29: 21972204.
  • 37
    Roy-Proulx, G., Meunier, M. C., Lanteigne, A. M., Brochu, S. and Perreault, C., Immunodomination results from functional differences between competing CTL. Eur. J. Immunol. 2001. 31: 22842292.
  • 38
    Willis, R. A., Kappler, J. W. and Marrack, P. C., CD8 T cell competition for dendritic cells in vivo is an early event in activation. Proc. Natl. Acad. Sci. USA 2006. 103: 1206312068.
  • 39
    Mempel, T. R., Henrickson, S. E. and von Andrian, U. H., T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004. 427: 154159.
  • 40
    Fisher, P. J., Bulur, P. A., Vuk-Pavlovic, S., Prendergast, F. G., and Dietz, A. B., Dendritic cell microvilli: a novel membrane structure associated with the multifocal synapse and T cell clustering. Blood 2008. 112: 50375045.
  • 41
    Liu, J., Ewald, B. A., Lynch, D. M., Nanda, A., Sumida, S. M. and Barouch, D. H., Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies. J. Virol. 2006. 80: 1199111997.
  • 42
    Radcliffe, J. N., Roddick, J. S., Friedmann, P. S., Stevenson, F. K. and Thirdborough, S. M., Prime-boost with alternating DNA vaccines designed to engage different antigen-presentation pathways generates high frequencies of peptide-specific CD8+ T cells. J. Immunol. 2006. 170: 66266633.
  • 43
    Sanderson, S. and Shastri, N., LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 1994. 6: 369376.